Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Five scientists walked into a lab late last year and decided to ...
AI automation throughout the drug development pipeline is opening up the possibility of faster, cheaper pharmaceuticals. At 82 years old, with an aggressive form of blood cancer that six courses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results